177Lu-PSMA-617
Bayer,Novartis
['crpc']
safety and survival outcomes in patients with #mcrpc treated with 177lu-psma after radium-223: interim analysis of the #ralu study. presented by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology